Search

everythinglearnresearchcommunity

for

Search:↓

EGCG may help treat alopecia areata by blocking certain immune responses and reducing specific harmful immune cells.

Alopecia areata patients have varied cancer risks, with some cancers being lower and others higher.

The MTHFR C677T mutation may increase the risk of alopecia areata in the Turkish population.

Activating Tgr5 may help treat hair loss and bone loss.

Vitamin D might be involved in the development of alopecia areata and could help in its treatment.

Oral cyclosporine is more effective and safer than betamethasone for treating alopecia areata.

Certain IL-18 gene variations may increase the risk of alopecia areata.

Hair regrows faster in alopecia areata than skin re-pigments in vitiligo due to differences in stem cells and treatment effects.

The model helps understand and improve treatments for alopecia areata by simulating hair growth and immune cell interactions.

Alopecia areata is more common in Black and Hispanic people but less diagnosed in those with lower socioeconomic status.

Alopecia areata can be an early sign of Hodgkin’s lymphoma and may improve with lymphoma treatment.

Platelet-rich plasma may help restore immune balance in bald patches, but its effectiveness in treating hair loss is limited.

People with certain types of alopecia have a slightly higher risk of cancer, especially thyroid, bladder, and prostate cancers.

88% phenol is effective for treating alopecia areata.

Alopecia Areata causes significant structural and compositional changes in hair.

Higher inflammation markers are linked to more severe alopecia areata.

Some people developed alopecia areata after COVID-19 vaccination, but it's not caused by the vaccine and most improved with treatment.

Wharton's jelly-derived stem cells were safely used to treat four alopecia patients, resulting in hair regrowth in all of them.

Alopecia areata involves complex immune and genetic factors, with potential treatment targets identified, but more research is needed.

Alopecia areata in children is caused by the immune system attacking hair follicles due to genetic factors.

Alopecia areata patients have fewer protective regulatory B cells, which may contribute to the disease.

Certain cytokines and growth factors can stop hair growth and may play a role in alopecia areata.

Clonally expanded CD8+ T cells cause alopecia areata.

The study was retracted.

Blocking Janus kinase 1 helps stop inflammation and regrow hair, making it a good treatment for hair loss from alopecia areata.

Our microbiome may affect the development of the hair loss condition Alopecia Areata, but more research is needed to understand this relationship.

Baricitinib helped some patients with tough-to-treat hair loss regrow hair, but more research is needed on its safety.

Gut bacteria may influence hair loss in alopecia areata.

Alopecia areata in Romania has a high economic burden, with significant costs and unequal healthcare access.